Digest Network Come funziona
Network
/
Società
Ir
Non verificato

Ironwood Pharmaceuticals, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteWeb e Social Network

21 comunicati stampa

Guarda tutti i comunicati
10/11/2025
Web e Social Network
Telefonia e Varie
Industria
Mercato azionario
Salute
Sanità
Scienza
Farmaceutica
Biotecnologia
Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance
Fonte
Ironwood Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
07/08/2025
Biotecnologia
Sanità
Salute
Farmaceutica
Medicina - Varie
Mercato azionario
Industria
Web e Social Network
Telefonia e Varie
Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance
Fonte
Ironwood Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
07/05/2025
Web e Social Network
Telefonia e Varie
Mercato azionario
Biotecnologia
Sanità
Salute
Farmaceutica
Medicina - Varie
Ironwood Pharmaceuticals Reports First Quarter 2025 Results
Fonte
Ironwood Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
30/04/2025
Eventi
Web e Social Network
Salute
Sanità
Scienza
Farmaceutica
Biotecnologia
Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference
Fonte
Ironwood Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
25/04/2025
Pubblico Esercizio/Vendita al dettaglio
Biotecnologia
Farmaceutica
Salute
Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance
Fonte
Ironwood Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
22/04/2025
Eventi
Fiere
Industria
Salute
Sanità
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support
Fonte
Ironwood Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
14/04/2025
Industria
Salute
Igiene alimentare
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide
Fonte
Ironwood Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
27/03/2025
Biotecnologia
Farmaceutica
Salute
Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing
Fonte
Ironwood Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
27/02/2025
Biotecnologia
Farmaceutica
Salute
Web e Social Network
Telefonia e Varie
Mercato azionario
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance
Fonte
Ironwood Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
20/02/2025
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call
Fonte
Ironwood Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0